Federal Circuit Affirms Pepcid Patent's Invalidity
A federal appellate court has affirmed a lower court ruling finding a patent for Johnson & Johnson and Merck & Co.'s popular over-the-counter heartburn drug Pepcid Complete invalid....To view the full article, register now.
Already a subscriber? Click here to view full article